Orthobiologics Market Prospective Growth, Opportunities | MarketsandMarkets™

1. Global Orthobiologics Market Prospective Growth, Opportunities | MarketsandMarkets™ According to the new market research report " Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, The global orthobiologics market is expected to reach USD 6.06 Billion by 2022 from USD 4.44 Billion in 2016 at a CAGR of 5.4% during the forecast period. Don’t miss out on business opportunities in Orthobiologics Market Orthobiologics Market : Years considered for the study are as follows •Base Year: 2016 •Forecast Period: 2017–2022 Orthobiologics Market : Objectives of the study are •To define, describe, and forecast the orthobiologics market on the basis of product, application, end user, and region •To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges) •To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the market

2. •To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders To know about the assumptions considered for the study, download the pdf brochure Browse and in-depth TOC on "Orthobiologics Market" 60 - Tables 38 - Figures 159 - Pages Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162747970 This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects. As of 2016, Medtronic, DePuy Synthes, and Zimmer Biomet held the leading position in the market. These companies adopted product launches, agreements, and partnerships as their business strategies in past three years to ensure market dominance. Stryker, Bioventus, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, NuVasive, SeaSpine, and Xtant Medical are some of the other major players in this market. Company Information Detailed analysis and profiling of additional orthobiologics market players (up to 15) The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the market. To speak to our analyst for a discussion on the above findings, click Speak to Analyst